Wealthspire Advisors (Maryland)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Wealthspire Advisors (Maryland)'s AMGN Position: Q3 2020 in Review
Wealthspire Advisors (Maryland) reduced its Amgen (AMGN) stake by 40% in Q3 2020, selling an estimated $1.05M and leaving 6,266 shares worth $1.59M. The position accounts for 0.06% of the portfolio, ranked #150.
Wealthspire Advisors (Maryland) first reported a position in AMGN in Q4 2015 and has held it in 20 quarters since. The position peaked at $2.48M in Q2 2020. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.
- Wealthspire Advisors (Maryland) held 6,266 shares of Amgen worth $1.59M as of Q3 2020.
- Wealthspire Advisors (Maryland) sold 4,234 Amgen shares in Q3 2020, an estimated $1.05M.
- Amgen made up 0.06% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #150 holding.
- Wealthspire Advisors (Maryland) first reported a position in Amgen in Q4 2015 and has held it in 20 quarters since.
- Wealthspire Advisors (Maryland)'s Amgen position peaked at $2.48M in Q2 2020.
- 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.